tiprankstipranks
Heidelberg Pharma AG (DE:HPHA)
:HPHA
Germany Market

Heidelberg Pharma AG (HPHA) Financial Statements

Compare
0 Followers

Heidelberg Pharma AG Financial Overview

Heidelberg Pharma AG's market cap is currently €122.09M. The company's EPS TTM is €-0.402; its P/E ratio is ―; Heidelberg Pharma AG is scheduled to report earnings on July 10, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 9.86M€ 18.51M€ 1.75M€ 8.49M€ 7.31M
Gross Profit€ 6.61M€ 13.83M€ -2.96M€ 2.89M€ 3.57M
Operating Income€ -21.21M€ -18.33M€ -25.63M€ -18.56M€ -10.36M
EBITDA€ -18.71M€ -16.19M€ -24.83M€ -17.55M€ -9.60M
Net Income€ -20.35M€ -19.70M€ -26.63M€ -18.37M€ -10.15M
Balance Sheet
Cash & Short-Term Investments€ 43.44M€ 81.33M€ 6.14M€ 4.98M€ 9.88M
Total Assets€ 70.35M€ 100.58M€ 21.73M€ 19.61M€ 22.99M
Total Debt€ 5.83M€ 15.98M€ 10.63M€ 202.68K€ 0.00
Net Debt€ -37.61M€ -65.35M€ 4.49M€ -4.78M€ -9.88M
Total Liabilities€ 21.01M€ 33.94M€ 15.03M€ 6.73M€ 6.70M
Stockholders' Equity€ 49.34M€ 66.64M€ 6.70M€ 12.88M€ 16.29M
Cash Flow
Free Cash Flow€ -34.63M€ -9.48M€ -28.00M€ -19.33M€ -9.52M
Operating Cash Flow€ -33.67M€ -8.86M€ -26.61M€ -17.89M€ -8.56M
Investing Cash Flow€ 5.85M€ -597.57K€ -1.40M€ -1.29M€ -975.80K
Financing Cash Flow€ -10.05M€ 84.00M€ 29.17M€ 14.29M€ -1.00
Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History

Heidelberg Pharma AG Debt to Assets

Heidelberg Pharma AG Cash Flow

Heidelberg Pharma AG Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis